Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2006 1
2007 2
2008 1
2009 2
2011 2
2012 2
2013 4
2014 4
2015 3
2016 1
2017 1
2018 2
2019 2
2021 5
2022 5
2023 1
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).
Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, de Jong MM, Links TP, Brems H, Aerden M, Brunet J, Lleuger-Pujol R, Hüneburg R, Aretz S, Colas C, Villy MC, Woodward ER, Evans DG, Bosch DGM, Donze SH, Foretová L, Blatnik A, Leter EM, Tischkowitz M, Jahn A, de Putter R, Dupont J, Briskemyr S, Steinke-Lange V, Baldassarri M, Anastasiadou VC, Irmejs A, Oliveira C, van der Post RS, Mensenkamp AR, Tesi B, Mu N, Benusiglio PR, Gerasimenko A, Innella G, Turchetti D, Houdayer C, Branchaud M, Høberg Vetti H, Tveit Haavind M, Balmaña J, Torres M, Genuardi M, Panfili A, Jørgensen K, Mæhle L, Hoogerbrugge N, Vos JR. Hendricks LAJ, et al. Among authors: irmejs a. Genet Med. 2025 Oct;27(10):101467. doi: 10.1016/j.gim.2025.101467. Epub 2025 May 24. Genet Med. 2025. PMID: 40433764 Free article.
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study.
Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, de Putter R, Brems H, Van Daele SH, Anastasiadou VC, Foretová L, Benusiglio PR, Gerasimenko A, Colas C, Villy MC, Houdayer C, Branchaud M, Hüneburg R, Aretz S, Jahn A, Steinke-Lange V, Innella G, Turchetti D, Barili V, Genuardi M, Panfili A, Baldassarri M, Irmejs A, de Jong MM, Links TP, Leter EM, Bosch DGM, Donze SH, van der Post RS, Mensenkamp AR, Westdorp H, Høberg-Vetti H, Tveit Haavind M, Jørgensen K, Mæhle L, Briskemyr S, Garcia JD, Blatnik A, Balmaña J, Torres M, Brunet J, Lleuger-Pujol R, Tham E, Tischkowitz M, Evans DG, Hyder Z, Hoogerbrugge N, Vos JR. Hendricks LAJ, et al. Among authors: irmejs a. BJC Rep. 2025 Jun 4;3(1):42. doi: 10.1038/s44276-025-00157-y. BJC Rep. 2025. PMID: 40468016 Free PMC article.
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
Hendricks LAJ, Hoogerbrugge N, Venselaar H, Aretz S, Spier I, Legius E, Brems H, de Putter R, Claes KBM, Evans DG, Woodward ER, Genuardi M, Brugnoletti F, van Ierland Y, Dijke K, Tham E, Tesi B, Schuurs-Hoeijmakers JHM, Branchaud M, Salvador H, Jahn A, Schnaiter S, Anastasiadou VC, Brunet J, Oliveira C, Roht L, Blatnik A, Irmejs A; PTEN Study Group; Mensenkamp AR, Vos JR. Hendricks LAJ, et al. Among authors: irmejs a. Eur J Med Genet. 2022 Dec;65(12):104632. doi: 10.1016/j.ejmg.2022.104632. Epub 2022 Oct 18. Eur J Med Genet. 2022. PMID: 36270489 Free article.
Blood Arsenic Levels as a Marker of Breast Cancer Risk among BRCA1 Carriers.
Marciniak W, Matoušek T, Domchek S, Paradiso A, Patruno M, Irmejs A, Roderte I, Derkacz R, Baszuk P, Kuświk M, Cybulski C, Huzarski T, Gronwald J, Dębniak T, Falco M, Lener MR, Jakubowska A, Pullella K, Kotsopoulos J, Narod S, Lubiński J. Marciniak W, et al. Among authors: irmejs a. Cancers (Basel). 2021 Jul 3;13(13):3345. doi: 10.3390/cancers13133345. Cancers (Basel). 2021. PMID: 34283078 Free PMC article.
Pregnancy after breast cancer in BRCA1/2 mutation carriers.
Maksimenko J, Irmejs A, Gardovskis J. Maksimenko J, et al. Among authors: irmejs a. Hered Cancer Clin Pract. 2022 Jan 21;20(1):3. doi: 10.1186/s13053-022-00209-1. Hered Cancer Clin Pract. 2022. PMID: 35062994 Free PMC article. Review.
A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review.
Loza P, Irmejs A, Daneberga Z, Miklasevics E, Berga-Svitina E, Subatniece S, Maksimenko J, Trofimovics G, Tauvena E, Ukleikins S, Gardovskis J. Loza P, et al. Among authors: irmejs a. Hered Cancer Clin Pract. 2021 Jan 19;19(1):11. doi: 10.1186/s13053-021-00168-z. Hered Cancer Clin Pract. 2021. PMID: 33468216 Free PMC article.
Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review.
Pavlovica K, Irmejs A, Noukas M, Palover M, Kals M, Tonisson N, Metspalu A, Gronwald J, Lubinski J, Murmane D, Kalnina A, Loza P, Maksimenko J, Trofimovics G, Subatniece S, Daneberga Z, Miklasevics E, Gardovskis J. Pavlovica K, et al. Among authors: irmejs a. Eur J Med Genet. 2022 May;65(5):104477. doi: 10.1016/j.ejmg.2022.104477. Epub 2022 Mar 18. Eur J Med Genet. 2022. PMID: 35314380 Review.
43 results